Capsigen Email Format
Biotechnology ResearchWashington, United States2-10 Employees
Capsigen is a small biotechnology research company based in Vancouver, Washington. It focuses on engineering adeno-associated virus capsids to enable gene therapies. The work aims to improve vector potency and cell-type specificity so therapies align with the biology of the disease. Its customers are developers of gene therapies seeking more precise delivery to target tissues and disease contexts. Capsigen has engaged in industry collaboration, including a strategic partnership with Biogen to engineer novel AAV capsids for CNS and neuromuscular disorders.